ATE361335T1 - Wasserlösliche polymere für die verminderung der absorption von diätetikem phosphat oder oxalat - Google Patents

Wasserlösliche polymere für die verminderung der absorption von diätetikem phosphat oder oxalat

Info

Publication number
ATE361335T1
ATE361335T1 AT97911925T AT97911925T ATE361335T1 AT E361335 T1 ATE361335 T1 AT E361335T1 AT 97911925 T AT97911925 T AT 97911925T AT 97911925 T AT97911925 T AT 97911925T AT E361335 T1 ATE361335 T1 AT E361335T1
Authority
AT
Austria
Prior art keywords
oxalate
phosphate
water soluble
polymer
soluble polymers
Prior art date
Application number
AT97911925T
Other languages
English (en)
Inventor
N Jaime Sim
Tipton Thomas Masterson
Alan D Strickland
Martha L Hilton
Original Assignee
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc filed Critical Dow Global Technologies Inc
Application granted granted Critical
Publication of ATE361335T1 publication Critical patent/ATE361335T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/22—Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
    • C08G65/24—Epihalohydrins
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/22—Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
    • C08G65/223—Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring containing halogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyethers (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT97911925T 1996-10-23 1997-10-22 Wasserlösliche polymere für die verminderung der absorption von diätetikem phosphat oder oxalat ATE361335T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2899396P 1996-10-23 1996-10-23

Publications (1)

Publication Number Publication Date
ATE361335T1 true ATE361335T1 (de) 2007-05-15

Family

ID=21846646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97911925T ATE361335T1 (de) 1996-10-23 1997-10-22 Wasserlösliche polymere für die verminderung der absorption von diätetikem phosphat oder oxalat

Country Status (14)

Country Link
US (1) US20020064511A1 (de)
EP (1) EP0934352B1 (de)
JP (1) JP4358303B2 (de)
KR (1) KR20000052744A (de)
CN (1) CN1238789A (de)
AT (1) ATE361335T1 (de)
AU (1) AU735056B2 (de)
BR (1) BR9712660A (de)
CA (1) CA2269586A1 (de)
DE (1) DE69737688T2 (de)
IL (1) IL129514A0 (de)
NZ (1) NZ335329A (de)
TR (1) TR199901613T2 (de)
WO (1) WO1998017707A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6190649B1 (en) * 1999-04-23 2001-02-20 Geltex Pharmaceuticals, Inc. Polyether-based bile acid sequestrants
AU7879500A (en) * 1999-10-15 2001-04-30 Dow Global Technologies Inc. Dialysis solution including polyglycol osmotic agent
US8263112B2 (en) 2000-11-20 2012-09-11 Sorbent Therapeutics, Inc. In vivo use of water absorbent polymers
EP1847271A3 (de) * 2000-11-20 2008-08-06 Sorbent Therapeutics, Inc. Wasser-absorbierende Polymere und ihre Verwendung als Arzneimittel
AU2002232955A1 (en) * 2000-11-20 2002-05-27 Dow Global Technologies Inc. In vivo use of water absorbent polymers
WO2002085381A1 (en) * 2001-04-18 2002-10-31 Genzyme Corporation Method for treating gout and binding uric acid
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
ES2453048T3 (es) 2004-03-30 2014-04-03 Relypsa, Inc. Polímeros de unión de ión y usos de los mismos
US20050276781A1 (en) * 2004-06-09 2005-12-15 Ross Edward A Molecularly imprinted phosphate binders for therapeutic use
CN102712752B (zh) * 2009-12-29 2015-07-08 日本瑞翁株式会社 聚醚橡胶、橡胶组合物、交联橡胶和导电部件
DE202023107635U1 (de) * 2023-12-22 2024-02-08 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320317A (en) * 1963-07-09 1967-05-16 Dow Chemical Co Quaternary ammonium adducts of polyepichlorohydrin
ZA703562B (en) * 1969-06-30 1971-01-27 Firestone Tire & Rubber Co Quaternary ammonium derivatives of epichlorohydrin polymers and a process of flocculation therewith
US3898185A (en) * 1973-08-10 1975-08-05 Dow Chemical Co Shelf-stable electroconductive latex composition
US3850857A (en) * 1973-08-20 1974-11-26 Goodrich Co B F Process for the polymerization of epihalohydrin employing a trialkyl oxonium salt of an hmf6 acid as catalyst
US3864288A (en) * 1973-10-15 1975-02-04 Goodrich Co B F Quaternized polyepihalohydrin thickening agent
US4056510A (en) * 1975-01-23 1977-11-01 The Dow Chemical Company Amine-modified polyethers
JPS572337A (en) * 1980-06-05 1982-01-07 Sumitomo Chem Co Ltd Preparation of cationic polymer
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration

Also Published As

Publication number Publication date
AU735056B2 (en) 2001-06-28
AU4918997A (en) 1998-05-15
CA2269586A1 (en) 1998-04-30
TR199901613T2 (xx) 1999-10-21
IL129514A0 (en) 2000-02-29
EP0934352B1 (de) 2007-05-02
NZ335329A (en) 2001-06-29
BR9712660A (pt) 2000-10-24
JP4358303B2 (ja) 2009-11-04
CN1238789A (zh) 1999-12-15
EP0934352A1 (de) 1999-08-11
US20020064511A1 (en) 2002-05-30
WO1998017707A1 (en) 1998-04-30
DE69737688D1 (de) 2007-06-14
DE69737688T2 (de) 2008-01-31
JP2001503457A (ja) 2001-03-13
KR20000052744A (ko) 2000-08-25

Similar Documents

Publication Publication Date Title
ATE361335T1 (de) Wasserlösliche polymere für die verminderung der absorption von diätetikem phosphat oder oxalat
ZA971766B (en) Process for preparing phosphonate-terminated polymers.
NZ315275A (en) Inhalant composition including ultra low mw heparins (ULMWH) to treat asthma
DE3880577D1 (de) Heparinderivate, verfahren zu deren herstellung und verwendung fuer pharmazeutische zwecke.
MY131507A (en) Polymers functionalize by koch reaction and derivatives thereof
BR9911754B1 (pt) copolìmero linear de ciclodextrina, solúvel em água, composição terapêutica, processo de preparo de um copolìmero linear de ciclodextrina, solúvel em água, e, processo de prepraro de um copolìmero linear de ciclodextrina oxidada, solúvel em água.
ATE186650T1 (de) Strahlenundurchlässige polymere und verfahren zu ihre herstellung
DE69428122D1 (de) Phosphatbindende polymere für orale verabreichung
ATE308637T1 (de) Adehyde enthaltende polymere als nassfestmittel
ZA972565B (en) Temporary wet strength additives.
NO853081L (no) Fremgangsmåte ved fremstilling av papri med høyt fyllstoffinnhold.
GB9916279D0 (en) Cellulose derivatives
ATE400578T1 (de) Photosensibilatoren, die galectin erkennen, für photodynamische therapie
DE3687570D1 (de) Aromatisches polymer und verfahren zu dessen herstellung.
EP1029863A4 (de) Camptothecin-derivate
ATE24921T1 (de) Wasserloesliche polymere mit hohem molekulargewicht.
ATE127104T1 (de) Dithiocarbamat-gruppen enthaltende polymere.
EP0913420A3 (de) Silphenylensilalkylenpolymer, Verfahren zu seiner Herstellung und Beschichtungszusammensetzung
ATE310764T1 (de) Verbessertes verfahren zur herstellung von polytetrahydrofuran
DE3468458D1 (en) Manufacture of paper using copolymers of 2-acrylamido-2-methylpropane sulfonic acid for increasing rate of dewatering of high mechanical/thermomechanical pulp furnishes
DE3267410D1 (en) Amide-imide derivatives of homopolymers of itaconic anhydride having antitumor activity
AU5111490A (en) Aerosol compositions intended for the imaging, diagnosis and targeted therapy of inflammatory and tumour foci
EP1226821A3 (de) Verwendung von 2,3-Alkylcarbonyloxybenzoesäure zur Behandlung des Atemunwohlseinsyndroms bei Erwachsenen
NO954454L (no) Fremgangsmåte ved polymerisering
BG102009A (en) Method for the treatment of manic and two-pole disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties